Kailera Therapeutics (KLRA) AI Analysis

KLRA$13.27+0.06 +0.45%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$1.72BEnterprise value$1.65BRevenue (TTM)$0Market position—

Score

72
Bullish
Value
70
Quality
47
Growth
100

Kailera Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 72/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~217% upside.

Kailera Therapeutics (KLRA) AI Analysis

KLRA price $13.27 +0.06 +0.45%

Ticker
KLRA
Price
$13.27
Change
+0.06 +0.45%
Market cap
$1.72B
Dividend yield
0.00%
Beta
0.50
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
72
Value
70
Quality
47
Growth
100

Stocklytics score rationale: value 70, quality 47, growth 100.

Fair value

KLRA fair value Not meaningful. Price $13.27.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 28.4, a blend of the industry median and the stock's own 10-year median. How we calculate it →

Not meaningful

Compare KLRA

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-26—-0.85——
2027-03-03—-0.90——
2026-11-04-0.74-0.73——
2026-08-12-1.09-0.90——
2026-05-26-3,650.00-0.78——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-07Nicholson NurBuy220.00K$16.233.57M
2026-08-31Nicholson NurOther0——
2026-07-06Tregoning KathleenBuy175.00K$23.304.08M
2026-06-29Tregoning KathleenOther0——
2026-06-09Renaud Ronald C JRSell38.09K$5.25199.99K
2026-06-09Renaud Ronald C JRBuy38.09K$5.25199.99K
2026-04-20RTW INVESTMENTS, LPBuy500.00K$16.008.00M
2026-04-20RTW INVESTMENTS, LPBuy10.28M——
2026-04-20RTW INVESTMENTS, LPSell8.25M——
2026-04-20RTW INVESTMENTS, LPSell2.03M——
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.Buy9.48M——
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.Buy2.03M——
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.Sell708.81K——
2026-04-20Jiangsu Hengrui Pharmaceuticals Co., Ltd.Sell4.97M——
2026-04-20BAIN CAPITAL INVESTORS LLCBuy8.40M$16.00134.38M
2026-04-20BAIN CAPITAL INVESTORS LLCBuy17.86M——
2026-04-20BAIN CAPITAL INVESTORS LLCSell17.86M——
2026-04-20Koppel AdamBuy1.56M$16.0025.00M
2026-04-20Koppel AdamBuy4.15M——
2026-04-20Koppel AdamBuy16.88M——
2026-04-20Koppel AdamSell16.88M——
2026-04-20Koppel AdamSell4.15M——
2026-04-20Bain Capital Life Sciences Investors, LLCBuy1.56M$16.0025.00M
2026-04-20Bain Capital Life Sciences Investors, LLCBuy4.15M——
2026-04-20Bain Capital Life Sciences Investors, LLCBuy16.88M——
2026-04-20Bain Capital Life Sciences Investors, LLCSell16.88M——
2026-04-20Bain Capital Life Sciences Investors, LLCSell4.15M——
2026-04-20Kaplan Andrew T.Buy8.40M$16.00134.38M
2026-04-20Kaplan Andrew T.Buy17.86M——
2026-04-20Kaplan Andrew T.Sell17.86M——
2026-04-16Koppel AdamBuy38.30K$16.00612.80K
2026-04-16Kaplan Andrew T.Buy38.30K$16.00612.80K
2026-04-16Cloghessy PaulaBuy60.00K$16.00960.00K
2026-04-16Akamine ScottBuy60.00K$16.00960.00K
2026-04-16Renaud Ronald C JRBuy300.00K$16.004.80M
2026-04-16Burgess Paul D.Buy100.00K$16.001.60M
2026-04-16MILLIGAN JOHN FBuy38.30K$16.00612.80K
2026-04-16Coleman Jamie BethBuy75.00K$16.001.20M
2026-04-16MACKAY MARTINBuy38.30K$16.00612.80K
2026-04-16Wasserman Scott M.Buy100.00K$16.001.60M
2026-04-16Hite ChristopherBuy38.30K$16.00612.80K
2026-04-16Clyburn FrankBuy38.30K$16.00612.80K
2026-04-16Pagan Douglas W.Buy100.00K$16.001.60M
2026-04-16Jiangsu Hengrui Pharmaceuticals Co., Ltd.Other0——
2026-04-16Jiangsu Hengrui Pharmaceuticals Co., Ltd.Other0——
2026-04-16Jiangsu Hengrui Pharmaceuticals Co., Ltd.Other0——
2026-04-16Koppel AdamOther0——
2026-04-16Koppel AdamOther0——
2026-04-16BAIN CAPITAL INVESTORS LLCOther0——
2026-04-16Bain Capital Life Sciences Investors, LLCOther0——
2026-04-16Bain Capital Life Sciences Investors, LLCOther0——
2026-04-16Kaplan Andrew T.Other0——
2026-04-16Burgess Paul D.Other0$7.240
2026-04-16Burgess Paul D.Other0$5.250
2026-04-16Burgess Paul D.Other0$5.250
2026-04-16Wasserman Scott M.Other0$5.250
2026-04-16Wasserman Scott M.Other0$5.250
2026-04-16Wasserman Scott M.Other0$7.240
2026-04-16Pagan Douglas W.Other0$10.090
2026-04-16Coleman Jamie BethOther0$5.400
2026-04-16Coleman Jamie BethOther0$7.240
2026-04-16RTW INVESTMENTS, LPOther0——
2026-04-16RTW INVESTMENTS, LPOther0——
2026-04-16MACKAY MARTINOther0$11.560
2026-04-16Liu YutingOther0——
2026-04-16Hite ChristopherOther0$7.240
2026-04-16Hite ChristopherOther0$5.400
2026-04-16Cloghessy PaulaOther0$7.240
2026-04-16Cloghessy PaulaOther0$5.250
2026-04-16Cloghessy PaulaOther0$5.400
2026-04-16Cloghessy PaulaOther0$5.250
2026-04-16Renaud Ronald C JROther0$7.240
2026-04-16Renaud Ronald C JROther0$5.250
2026-04-16Renaud Ronald C JROther0$5.250
2026-04-16Renaud Ronald C JROther0$5.250
2026-04-16Renaud Ronald C JROther0$7.240
2026-04-16Renaud Ronald C JROther0$5.250
2026-04-16Renaud Ronald C JROther0$7.240
2026-04-16Clyburn FrankOther0$7.240
2026-04-16Akamine ScottOther0$5.250
2026-04-16Akamine ScottOther0$7.240
2026-04-16Akamine ScottOther0$5.250
2026-04-16MILLIGAN JOHN FOther0$7.240
2026-04-16MILLIGAN JOHN FOther0$5.250
2026-04-16CANADA PENSION PLAN INVESTMENT BOARDOther0——
2026-04-16Stuart Partners, LLCOther0——

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 81. Ownership 31.79%.

HolderSharesChangeChange %Value
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC5.17MNewNew59.06M
FMR LLC4.66MNewNew53.22M
BLACKROCK, INC.4.57MNewNew52.22M
ROYALTY PHARMA SUB-MANAGER, LLC2.46MNewNew28.04M
STATE STREET CORP2.24MNewNew25.60M
SIREN, L.L.C.2.21MNewNew25.29M
VANGUARD CAPITAL MANAGEMENT LLC1.68MNewNew19.21M
VANGUARD PORTFOLIO MANAGEMENT LLC1.62MNewNew18.50M
GEODE CAPITAL MANAGEMENT, LLC1.21MNewNew13.79M
MARSHALL WACE, LLP878.20KNewNew10.03M
UBS GROUP AG469.58KNewNew5.36M
FRANKLIN TEMPLETON INC401.44KNewNew5.14M
ABERDEEN GROUP PLC432.66KNewNew4.94M
WALLEYE CAPITAL LLC416.85KNewNew4.76M
FEDERATED HERMES, INC.403.69KNewNew4.61M
JUMP FINANCIAL, LLC381.00KNewNew4.35M
BNP PARIBAS FINANCIAL MARKETS310.27KNewNew3.54M
VANGUARD FIDUCIARY TRUST CO290.14KNewNew3.31M
EXCHANGE TRADED CONCEPTS, LLC260.80KNewNew2.98M
RENAISSANCE TECHNOLOGIES LLC198.55KNewNew2.27M
ALPS ADVISORS INC171.74KNewNew1.96M
MORGAN STANLEY155.40KNewNew1.77M
HRT FINANCIAL LP151.00KNewNew1.72M
NUVEEN, LLC147.19KNewNew1.68M
BANK OF NEW YORK MELLON CORP140.93KNewNew1.61M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener